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Abstract: Propolis is a resin manufactured by bees through the mixture of plant exudates and
waxes with secreted substances from their metabolism, resulting in a complex mixture of natural
substances of which quality depends on the phytogeographic and climatic conditions around the
hive. The present study investigated the contribution of phenolic compounds to the cytotoxic
and anti-inflammatory activities of propolis. The phenolic composition was evaluated by liquid
chromatography with diode-array detection coupled to electrospray ionization tandem mass
spectrometry (LC/DAD/ESI-MSn) analysis after phenolic extraction. The cytotoxicity of the extracts
was checked using human tumor cell lines (MCF7- breast adenocarcinoma, NCI-H460- non-small cell
lung carcinoma, HeLa- cervical carcinoma, HepG2- hepatocellular carcinoma, and MM127- malignant
melanoma), as well as non-tumor cells (a porcine liver primary culture-PLP2). The anti-inflammatory
activity was assessed using the murine macrophage (RAW 264.7) cell line. The results showed a
composition rich in phenolic acids, such as caffeic and p-coumaric acid, as well as flavonoids, such
as pinocembrin, pinobanksin, and pinobanksin-3-O-butyrate. Samples MP2 from Sefrou and MP3
from Moulay Yaâcoub presented a high concentration in phenolic compounds, while MP1 and MP4
from Boulemane and Immouzzer Mermoucha, respectively, showed similar composition with low
bioactivity. The higher concentration of phenolic compound derivatives, which seems to be the
most cytotoxic phenolic class, can explain the pronounced antitumor and anti-inflammatory activity
observed for sample MP2.
Keywords: propolis; phenolic compounds; cytotoxicity; tumor cells; anti-inflammatory
1. Introduction
Plants and plant-derived products have proven to be rich sources of natural compounds, inducing
many applications as new pharmaceutical agents. Nowadays, more than 60% of anticancer compounds
come from natural products or substances derived from them, confirming interesting effects on cell lines
and murine models and yielding higher activity compared to synthetic compounds [1,2]. Additionally,
the combination of toxic natural products and monoclonal antibodies or polymeric carriers can lead to
more effective targeted therapies, enabling synergistic or additive effects, which allow lower treatment
concentrations and avoid multi-drug resistance, commonly developed when single drug molecules are
used [2–4]. Natural products or natural product-derivatives may provide such combinations for use
in chemotherapy and chemoprevention [3]. In recent years, modified natural products produced by
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bees, such as propolis, have been receiving great attention due to its wide spectrum of biological and
pharmaceutical properties [2].
Propolis is a bee product that worker honey bees (Apis mellifera L.) prepare from resins that
they collect from different plants and mix with beeswax. In some circumstances, bees may also cut
fragments of vegetative tissues to release the resin used in propolis production [5]. Bees make use of
propolis as a building material but also to defend the hive against pathogens [6]. It plays an important
role in the colony-level immunity defense since the sources of the resin are complex plant secretions
with high antimicrobial properties [7]. The chemical variability of propolis is strongly reliant on the
plant sources available around the hive, which depends on the geographic and climatic conditions of
the site, although bees show some preference for specific resin sources. This preference seems to be
linked to the sticky and resinous properties of the material, but there is also some evidence that bees
select plant resins rich in biologically active phytochemicals that fulfill their needs [5,7].
Propolis contains approximately 50% resin and vegetable balsam (phenolic compounds), 30%
of wax, 10% essential and aromatic oils, 5% pollen, and 5% other substances (amino acids, vitamins,
mineral salts), including organic debris [8,9]. It is known to possess valuable biological properties
such as antimicrobial, anti-inflammatory, antitumor and antioxidant activities, which are due to its
rich composition in phenolic compounds [10,11]. Within the most abundant compounds, we may
find flavonoids such as pinocembrin, pinobanksin, galangin and chrysin, common in propolis from
temperate regions where poplar are the main source of the resin, while prenylated phenylpropanoids,
like artepillin C, are found in Brazilian propolis with origin in Baccharis spp [5,12]. Numerous
scientific works have focused their research on propolis phenolic compounds as a potential tool for the
development of new drugs to use against cancer [10]. Several mechanisms of action against tumor
cells are described for propolis phenolic extracts, including induction of apoptosis, cell-cycle arrest,
inhibition of matrix metalloproteinases, anti-angiogenesis effect, and prevention of metastasis and
invasion [2,10,13,14].
Previous studies on Moroccan propolis extracts were shown to have in vitro and in vivo antitumor
potential against three mammalian tumor cell lines: BSR (hamster renal adenocarcinoma), Hep-2
(human laryngeal carcinoma) and P815 (murin mastocytoma) [15]. Other biological activities such as
antioxidant, antimicrobial [16], anti-inflammatory and acetylcholinesterase inhibitory activities [17]
were also reported. Biological properties research of such a complex matrix as propolis should
always be accompanied by chemical composition characterization of its botanical source, in order to
explore its bioactivity and interaction with its constituents. Therefore, the aim of this study was to
investigate the contribution of Moroccan propolis phenolic compounds to the bioactive properties of
Moroccan propolis, in particular the anti-inflammatory activity and the cytotoxicity on human tumor
cell lines (MCF-7—breast adenocarcinoma, NCI-H460—non-small cell lung carcinoma, HeLa—cervical
carcinoma, HepG2—hepatocellular carcinoma, MM127—human malignant melanoma) and non-tumor
primary cells (PLP2).
2. Materials and Methods
2.1. Standards and Reagents
Caffeic acid, p-coumaric acid, pinocembrin, chrysin, and caffeic acid phenylethyl ester (CAPE)
were purchased from Sigma Chemical Co (St Louis, MO, USA). Kaempferol and apigenin were acquired
from Extrasynthese (Genay, France). HPLC-grade methanol, ethanol, and acetonitrile were purchased
from Fisher Scientific (Leics, UK). Water was treated in a Milli-Q water purification system (TGI pure
system, Houston, TX, USA).
Fetal bovine serum (FBS), L-glutamine, Hank’s balanced salt solution (HBSS), trypsin-
ethylenediaminetetraacetic acid (EDTA), penicillin/streptomycin solution (100 U/mL and 100 mg/mL,
resp.), RPMI-1640, and DMEM media were purchased from Hyclone (Logan, UT, USA). Acetic acid,
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ellipticine, dexamethasone, sulforhodamine B (SRB), trypan blue, trichloroacetic acid (TCA), and tris
were obtained from Sigma Chemical Co. (Saint Louis, MO, USA).
2.2. Propolis Samples
The study was performed on propolis samples collected, by scratching, from four different
geographical locations, within the Fez region in Morocco: MP1 is from Boulemane (main vegetation:
Bupleurum, Ceratonia, Eucalyptus, Thymus and Rosmarinus), MP2 from Sefrou (main vegetation: Olea,
Pinus, Quercus, Juniperus, Rosmarinus, Cistus, Lavandula and Pistacia), MP3 from Moulay Yaâcoub (main
vegetation: Ceratonia, Citrus, Eucalyptus and Silybum) and MP4 from Immouzzer Mermoucha (main
vegetation: Populus, Ceratonia, Eucalyptus, Rosmarinus and Quercus). All the samples, with a similar
brownish colour, were gathered in 2018 and kept at −20 ◦C until analysis.
2.3. Propolis Phenolic Compounds Extraction
The phenolic compounds were obtained through a hydro-ethanolic extraction procedure [11].
Briefly, 1 g of sample was mixed with 10 mL of 80% of ethanol/water and kept at 70 ◦C for 1 h
under stirring. The resulting mixture was filtered and re-extracted in the same conditions. Finally,
the resulting extracts were combined, concentrated, and freeze-dried.
2.4. Chemical Characterization of the Samples by LC/DAD/ESI-MSn
The LC/DAD/ESI-MSn analyses were performed on a Dionex Ultimate 3000 UPLC instrument
(Thermo Scientific, San Jose, CA, USA) equipped with a diode-array detector and coupled to a mass
detector. The column used for high-performance liquid chromatography (HPLC) was a Macherey-Nagel
Nucleosil C18 (250 mm × 4 mm id; 5 mm particle diameter, end-capped) and its temperature was
maintained at 30 ◦C. The LC conditions used followed our previous work [12]. A flow rate of 1 mL/min
was applied; with an injection volume of 10 µL. Spectral data for all peaks were accumulated in the
range of 190–600 nm.
The mass spectrometer was operated in the negative ion mode using Linear Ion Trap LTQ XL
mass spectrometer (Thermo Scientific, CA, USA) equipped with an electrospray ionization (ESI) source.
ESI source parameters were as follows: Source voltage, 5 kV; capillary voltage, −20 V; tube lens voltage,
−65 V; capillary temperature, 325 ◦C; and sheath and auxiliary gas flow (N2) set as 50 and 10 (arbitrary
units), respectively. Mass spectra were acquired on full range acquisition covering 100–1000 m/z.
For the fragmentation study, a data dependent scan was performed by deploying collision-induced
dissociation (CID). The normalized collision energy of CID cell was set at 35 (arbitrary units). Data
acquisition was carried out with Xcalibur® data system (Thermo Scientific, San Jose, CA, USA).
The elucidation of the phenolic compounds was achieved by comparison of their chromatographic
behavior, UV spectra, and MS information, to those of reference compounds. When standards were not
available, the structural information was confirmed with UV data combined with MS fragmentation
patterns previously reported in the literature.
Quantification was achieved using calibration curves for caffeic acid (0.002–0.35 mg/mL;
y = 3 × 107x − 78,726; R2 = 0.999), p-coumaric acid (0.02–0.15 mg/mL; y = 5 × 107x − 94,095; R2 =
0.999), chrysin (0.0025–0.16 mg/mL; y = 2 × 107x − 7021; R2 = 0.999), kaempferol (0.005–0.075 mg/mL;
y = 6 × 106x − 2761; R2 = 0.999), and pinocembrin (0.005–1 mg/mL; y = 2 × 107x − 247,019; R2 =
0.999). When the standard was not available, the compound quantification was expressed in equivalent
terms of the structurally closest compound. The assays were performed in duplicate and the results
expressed as mg/g of extract.
2.5. Cytotoxic Activity
The cytotoxic effects were evaluated in five human tumor cell lines: MCF-7 (breast
adenocarcinoma), NCI-H460 (non-small cell lung cancer), HeLa (cervical carcinoma) and HepG2
(hepatocellular carcinoma), obtained from DSMZ (Leibniz-Institut DSMZ–Deutsche Sammlung von
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Mikroorganismen und Zellkulturen GmbH), and MM127 (human malignant melanoma) from the
ECACC General Cell Collection. All the cells were routinely maintained as adherent cell cultures
in RPMI-1640 medium, containing 10% FBS, 2 mM glutamine, 100 U/mL penicillin, and 100 µg/mL
streptomycin, and kept at 37 ◦C in a humidified air incubator containing 5% CO2. The cytotoxic
potential of the propolis samples was evaluated by the sulforhodamine B (SRB) assay, according to the
procedure described previously [18]. For hepatotoxicity evaluation, a cell culture was prepared from
a freshly harvested porcine liver obtained from a local slaughterhouse, according to an established
procedure, and designated as PLP2 (porcine liver primary culture). The cell cultivation was maintained,
with direct monitoring, every two to three days using a phase contrast microscope. Before confluence
was reached, cells were subcultured and plated in 96-well plates at a density of 1.0 × 104 cells/well,
and cultivated in DMEM medium with 10% FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin.
The propolis samples were dissolved in 50% DMSO:water to obtain a stock solution of 10 mg/mL.
Cells were treated with different concentrations of the samples (400–6.25 µg/mL) and SRB assay was
performed as previously described. The results were expressed as GI50 values in µg/mL (sample
concentration that inhibited 50% of the net cell growth). Ellipticine was used as a positive control.
2.6. Anti-Inflammatory Activity
The anti-inflammatory activity was evaluated using the murine macrophage (RAW 264.7) cell
line, obtained from ECACC General Cell Collection. Cells were routinely maintained as adherent cell
cultures in DMEM medium containing 10% FBS, 2 mM glutamine, 100 U/mL penicillin, and 100 µg/mL
streptomycin, and kept at 37 ◦C in a humidified air incubator containing 5% CO2 [19]. The extracts
were dissolved in DMSO/water (1:1) obtaining a stock solution with a final concentration of 10 mg/mL.
Nitric oxide (NO) production was studied with a Griess Reagent System kit. Results were expressed as
IC50 values (µg/mL), equal to the sample concentration providing a 50% inhibition of NO production.
The cells treatment and the nitric oxide determination was carried out as previously described [19] and
compared to the standard calibration curve (y = 0.073 + 0.1509; R2 = 0.999). Dexamethasone was used
as a positive control.
2.7. Statistical Analysis
All experiments were performed in duplicate. Results are expressed as mean values and standard
deviation (SD). The differences between samples were checked using analysis of variance (ANOVA)
followed by Tukey post hoc significant difference test with α = 0.05. Additionally, a multivariate
statistical analysis (Spearman rank correlation analysis) was performed to establish links between
propolis chemical composition and the biological activities, and to assess the relationship between
variables. The statistical analysis was performed using the program SPSS v. 20.0.
3. Results and Discussion
3.1. Moroccan Propolis Chemical Characterization
The chemical complex nature of propolis is linked to the resinous materials gathered by honey
bees from different floral sources available around the hive, which have a direct impact on the quality
and bioactivity of the propolis. Liquid chromatography coupled with mass spectrometry is a powerful
tool that can be used to overcome the difficult task of propolis chemical profiling [6].
The phenolic composition of the four propolis samples from Morocco was evaluated by
LC/DAD/ESI-MSn, with the identification of twenty-six phenolic compounds. Negative ion mode
was used in this study because of its higher analytical sensitivity for different polyphenol classes [12].
Caffeic acid, p-coumaric acid, pinobanksin, pinocembrin, chrysin, and pinobanksin-3-O-acetate
(Table 1) were present in all of the samples, and most likely arose from the common source of
the resin, the poplar tree. However, other species like Ulmus, Pinus, Quercus, Salix e Acacia, can
be also adequate sources for temperate propolis, particularly when poplars are unavailable [5].
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Some compounds were specific to only one sample, such as sterubin, 3-prenyl-p-coumaric acid,
dihydrokampferide, capillartimisin A, and isosakuranetin found in sample MP4 from Immouzzer
Mermoucha; pinobanksin-5-methyl-ether (3, m/z 285) present in sample MP1 from Boulemane;
apigenin, caffeic acid pentyl ester, pinobanksin-3-O-propionate, pinobanksin-3-O-butyrate, and
pinobanksin-3-O-pentanoate observed in MP2 from Sefrou; and benzoyl hydroxyphenyl acetic acid
only present in MP3 from Moulay Yaâcoub. Phenolic acid derivatives such as caffeic acid isoprenyl
ester, caffeic acid benzyl ester, and caffeic acid phenylethyl ester (CAPE) were observed in samples
MP1, MP2, and MP3, while flavonols such as kaempferol-methyl-ether, galangin and 6-methoxychrysin
were characteristic of MP2 and MP3 samples (Table 1). Besides the compounds mentioned above, the
composition of samples MP1 and MP4 included a chemical structure with m/z 377, which was not
possible to identify, and therefore described as unknown (Table 1). Overall, the phenolic composition
of the Moroccan propolis resembles other studies from the group [20], with a resin rich in flavonoid
aglycones and phenolic acid esters with similarities to the poplar propolis.
Figure 1 displays the quantification analysis for the different samples. There is an evident
difference between samples MP2 (30 mg/g of total phenolics) and MP3 (15mg/g of total phenolics),
with MP2 containing twice the amount of phenolics. Samples MP1 and MP4 presented the poorest
phenolic profile, with only twelve compounds identified and a total phenolic content of 9 and 12 mg/g
extract, respectively.
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Morocco origins.
In respect to the individual classes, dihydroflavonol derivatives, amongst them pinobanksin-3-O-
acetate, were the main compounds present in these Moroccan propolis samples, especially in sample
MP2. This was followed by the phenolic acids derivatives, where the phenolic acids esters emerge
as th major compounds (Fig re 1). Flavonols, such as kaempfe ol-methyl-ether and galangin wer
found as minor compounds, present only in samples MP2 and MP3 (Table 1).
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Table 1. Phenolic compounds in Moroccan propolis identified and quantified by LC/DAD/ESI-MSn (each value is the mean ± standard deviation, n = 2).
Peak Proposed Compound RT(min)
λmax
(nm)
[M − H]−
m/z
MSn
(% Base Peak)
MP1
mg/g Extract
MP2
mg/g Extract
MP3
mg/g Extract
MP4
mg/g Extract
1 Caffeic acid a,b 10.9 322 179 MS2 [179]: 135 0.31 ± 0.00 0.50 ± 0.00 0.31 ± 0.00 0.30 ± 0.00
2 p-Coumaric acid a,b 15.8 310 163 MS2 [163]: 119 0.22 ± 0.00 0.21 ± 0.00 0.16 ± 0.00 0.50 ± 0.00
3 Pinobanksin-5-methyl-ether b,c 36.9 286 285 MS2 [285]: 267 (100), 253 (13), 239 (27) 0.77 ± 0.01
4 Sterubin b,d 47.3 284 301 MS
2 [301]: 286 (100), 165 (8); MS3 [286]: 258 (37),
195 (17), 165 (100)
0.83 ± 0.01
5 Pinobanksin b,c 47.3 292 271 MS2 [271]: 253 (100), 225 (26), 151 (10) 0.83 ± 0.00 2.04 ± 0.00 1.14 ± 0.03 0.83 ± 0.01
6 Dihydrokaempferide b,e 50.4 291 301 MS
2 [301]: 283 (100), 151 (22); MS3 [283]: 268 (100),
255 (40), 227 (41)
0.86 ± 0.01
7 Apigenin a,b 54.9 268, 337 269 MS2 [269]: 225 (100), 151 (29) 0.27 ± 0.00
8 Kaempferol-methyl ether b,c 57.7 265, 352 299 MS2 [299]: 284 0.15 ± 0.01 0.26 ± 0.00
9 3-prenyl-p-coumaric acid b,e 63.6 315 231 MS2 [231]: 187; MS3 [187]: 132 0.71 ± 0.00
10 Caffeic acid isoprenyl ester a,b 65.2 325 247 MS2 [247]: 179 (100), 135 (13) 0.34 ± 0.00 1.73 ± 0.01 1.40 ± 0.00
11 Caffeic acid isoprenyl ester b,c 66.3 325 247 MS2 [247]: 179 (100), 135 (13) 0.35 ± 0.01 3.00 ± 0.01 2.59 ± 0.00
12 Capillartimisin A b,e 66.4 309 315 MS
2 [315]: 285 (60), 271 (100), 241 (67); MS3 [271]:
253 (41), 241 (100)
0.21 ± 0.00
13 Caffeic acid benzyl ester b,c 66.7 325 269 MS2 [269]: 178 (100), 161 (12), 134 (32) 0.43 ± 0.01 1.18 ± 0.03 0.90 ± 0.02
14 Pinocembrin a,b 67.6 289 255 MS2 [255]: 213 (100), 211 (32), 151 (48) 1.17 ± 0.04 3.91 ± 0.15 2.80 ± 0.03 1.81 ± 0.00
15 Isosakuranetin b,f,g 68.1 292 285 MS
2 [285]: 270 (100), 243 (25), 164 (17), 151 (4) MS3
[270]: 242 (41), 165 (100), 164 (70)
0.92 ± 0.00
16 Benzoyl hydroxyphenyl aceticacid b,f 68.4 280 257 MS
2 [257]: 213; MS3 [213]: 169 (100), 122 (49) 0.61 ± 0.02
17 Chrysin a,b 69.6 268, 313 253 MS2 [253]: 225 (17), 209 (100), 151 (5) 0.25 ± 0.08 1.99 ± 0.14 2.88 ± 0.01 0.27 ± 0.03
18 Pinobanksin-3-O-acetate b,c 69.6 292 313 MS2 [313]: 271 (20), 253 (100) 1.22 ± 0.02 6.82 ± 0.06 1.01 ± 0.00 0.96 ± 0.02
19 Caffeic acid phenylethyl ester a,b 69.9 325 283 MS2 [283]: 179 (100), 135 (22) 0.37 ± 0.02 1.24 ± 0.03 0.57 ± 0.00
20 Galangin a,b 70.3
265, 300sh,
358 269
MS2 [269]: 269 (100), 241 (61), 227 (20), 197 (22),
151 (20)
1.04 ± 0.02 0.35 ± 0.00
21 Caffeic acid pentyl ester b 71.1 325 249 MS2 [249]: 179 (100), 161 (47), 135 (32) 0.62 ± 0.00
22 6-Methoxychrysin b,c 72.3
265, 300sh,
350sh 283 MS
2 [283]: 269 0.88 ± 0.05 0.48 ± 0.04
23 Pinobanksin-3-O-propionate b,c 75.2 289 327 MS2 [327]: 271 (9), 253 (100) 1.08 ± 0.01
24 Unknown 79.5 239 377 MS2 [377]: 359 (100), 331 (84), 313 (8) 2.76 ± 0.04 4.31 ± 0.03
25 Pinobanksin-3-O-butyrate orisobutyrate b,c 79.9 292 341 MS
2 [341]: 271 (2), 253 (100) 2.66 ± 0.01
26 Pinobanksin-3-O-pentanoate or2-methylbutyrate b,c 84.1 292 355 MS
2 [355]: 271 (3), 253 (100) 0.80 ± 0.00
a Confirmed with standard; b Confirmed with MSn fragmentation; c Confirmed with references: [12]; d [21]; e [22]; f [23]; g [24].
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3.2. Cytotoxicity and Anti-Inflammatory Activity
The chemical compounds presented in the resin, which bees collect from plants to prepare propolis,
are, in general, powerful bioactive metabolites used by plants for protection against pathogens, and so,
are used by bees to immunize the hive environment [13]. Therefore, they may also function well as a
relevant source of bioactive substances for pharmaceutical purposes. With this in mind, the cytotoxicity
of the Moroccan propolis phenolic extracts was tested in five human tumor cell lines, including MCF-7
(breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), HeLa (cervical carcinoma), HepG2
(hepatocellular carcinoma), and MM127 (human malignant melanoma) as well as in a porcine liver
primary cell culture (PLP2), established by us. Also, the anti-inflammatory activity was evaluated
using the murine macrophage (RAW 264.7) cell line. The growth inhibition of the tumor cells was
observed in all the experiments, but particularly on sample MP2, which had the lowest cytotoxicity
GI50 values in three of the five cell lines (Figure 2), followed by MP3 with the best performance for
breast adenocarcinoma and lung cancer cells.
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SD, n = 2). GI50 values correspond to the extract concentration achieving 50% of growth inhibition in
human tumor cell lines or in liver primary culture PLP2.
Overall, growth inhibition GI50 results were lower compared to the ones reported by us in
Portuguese propolis [25]. The activity against HeLa cell line is particularly interesting for samples MP2
and MP3, with GI50 values of 9 µg/mL and 10 µg/mL, respectively (Figure 2), which is not as far from the
activity of the synthetic standard elliptimicine as we would expect for a mixture of natural substances.
On the opposite side is the sample MP4 from Immouzzer, with the weakest erformance against all the
tumor cell lines tested. Although it shows a richer composition in total phenolic compounds than MP1,
the poor performance can be explained by the low concentration of specific bioactive compounds,
such as those derived from the phenolic acids. Regardless of the high cytotoxicity exhibited by the
Moroccan propolis against the studied tumor cell lines, all the extracts displayed some toxicity for
non-tumor (normal) liver primary culture (PLP2). However, the values obtained for the tumor cells
were always below the ones for non-tumor cells, highlighted in the results obtained for HeLa, MCF-7
and MM127, especially in the case of samples MP2 and MP3 (Figure 2).
The reported bioactivity is most probably correlated with the phenolic composition of propolis.
Indeed, MP2 and MP3 as the samples with higher phenolic content were the ones with higher cytotoxicity.
Several mechanisms of action are described for the interaction of phenolic compounds with tumor
cells, including induction of apoptosis, cell-cycle arrest, inhibition of matrix metalloproteinases,
anti-angiogenesis effect, and prevention of metastasis and invasion [2,10,13,14].
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From Table 2 it is possible to retrieve additional information with respect to the correlation between
the bioactivity against the different cell lines, and the phenolic classes. Without any doubt, the phenolic
acid derivatives are the most active class, exhibiting a negative correlation (higher cytotoxicity) for all
the cell lines, and particularly against HeLa and MM127.
Table 2. Spearman’s correlations between the propolis phenolic composition (mg/g of extract) and
cytotoxicity and anti-inflammatory activity GI50/IC50 values (µg/mL).
NCI-H460 HeLa HepG2 MCF-7 MM127 PLP2 RAW264.7
Phenolic acids 0.786 a 0.381 0.786 a 0.452 0.357 0.881 a 0.357
Phenolic acid derivatives −0.810 a −0.976 b −0.762 a −0.833 a −0.952 b −0.500 −0.905 b
Dihydroflavonols 0.024 −0.381 0.024 −0.310 −0.357 0.429 −0.381
Dihydroflavonols derivatives −0.405 −0.810 a −0.357 −0.619 −0.738 a −0.310 −0.857 b
Flavonols −0.710 a −0.913 b −0.710 a −0.862 b −0.888 b −0.317 −0.875 b
Flavones −0.881 b −0.619 −0.881 b −0.690 −0.690 −0.548 −0.500
Flavanones −0.619 −0.786 a −0.571 −0.643 −0.762 a −0.167 −0.667
Total phenolics −0.595 −0.762 a −0.548 −0.667 −0.786 a −0.143 −0.643
Spearman’s correlation significance levels: a Correlation is significant at p < 0.05; b Correlation is significant at
p < 0.01.
This class of compounds, which includes phenolics such as caffeic acid phenylethyl ester (CAPE),
observed in higher amounts in samples MP2 and MP3, is reported to play a key role in the bioactivity
of propolis extracts, including against rat glioma C6, human squamocosal carcinoma, breast murine
B16F10, human breast adenocarcinoma, and different leukemia cells [26]. The cytotoxicity of flavones
seems to be more selective, with greater correlation to lung and hepatocellular carcinoma (Table 2).
Indeed, compounds such as chrysin, found in higher amounts in propolis, have been shown to act
against Murine B16F10, human colon carcinoma HCT-15 and human hepatoma Hep-3B cells [14].
One of the classes most represented in the Moroccan propolis samples under study, the
dihydroflavonols derivatives, seems to correlate only with cervical carcinoma HeLa and malignant
melanoma, MM127. These findings corroborate previous studies on Moroccan propolis extracts,
which also observed an anti-proliferative effect against other skin tumor cells such as P815 (murine
mastocytoma), in addition to effects against BSR (hamster renal adenocarcinoma) and Hep-2 (Human
laryngeal carcinoma) [15]. Recently, dihydroflavonols such as pinobanksin and its derivatives, for
example pinobanksin-3-O-acetate, were described to exert an anti-proliferative effect, induced through
apoptosis in a B-cell lymphoma cancer cell line [27]. Furthermore, it was reported that the anti-metastatic
effectiveness of the entire propolis extract was higher than that presented by its individual constituents,
resulting in a synergistic effect between constituents [13]. Overall, these compounds are described to
target various genetic and biochemical pathways of cancer progression like induction of apoptosis,
cell-cycle arrest, inhibition of matrix metalloproteinases, anti-angiogenesis effect, and prevention of
metastasis and invasion [10,14,26].
The anti-inflammatory effect, whose results are summarized in Figure 3, was assessed using
murine macrophage-like RAW 264.7 cells and quantified through the nitric oxide (NO) production.
All propolis extracts under study showed anti-inflammatory capacity, with IC50 values between
14 and 52 µg/mL. The highest activity was observed for sample MP2, which contains a higher quantity
of bioactive compounds such as phenolic acid derivatives and flavones, followed by the sample
MP3, with an IC50 value of 29 µg/mL. It is worth mentioning the great performance of sample MP2,
which displayed an even higher anti-inflammatory activity than the positive control dexamethasone.
Compounds such as phenolic acid derivatives, flavonols, and dihydroflavonols derivatives, seem
to be the major responsible substances, as considering their significant negative correlation with
anti-inflammatory activity (Table 2). This also may explain the fact that, despite the low concentration
of phenolic compounds in sample MP1, its anti-inflammatory activity was similar to that of sample
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MP3, which can be attributed to the higher concentration of dyhidroflavonols derivatives in the
chemical composition of sample MP1 as compared to sample MP3 (Figure 1).
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